Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Cervical Cancer

  Free Subscription


2 Acta Radiol
1 Arch Med Res
1 Cancer Cell Int
5 Cancer Manag Res
3 Cancers (Basel)
1 Cell Mol Biol (Noisy-le-grand)
1 Clin Lab
2 Enferm Clin
1 Eur J Cancer
1 Front Immunol
1 Gynecol Oncol
1 Int J Gynecol Cancer
1 Int J Med Sci
1 J Cancer Educ
1 J Minim Invasive Gynecol
2 Lancet Oncol
1 mBio
1 Medicine (Baltimore)
3 Onco Targets Ther
1 Panminerva Med
1 Pathol Res Pract
1 Pharmazie
1 Pharmgenomics Pers Med
1 Sci Rep
1 Support Care Cancer

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Radiol

  1. ZHANG A, Song J, Ma Z, Chen T, et al
    Application of apparent diffusion coefficient values derived from diffusion-weighted imaging for assessing different sized metastatic lymph nodes in cervical cancers.
    Acta Radiol. 2020;61:848-855.
    PubMed         Abstract available

  2. DONG Y, Dong RT, Zhang XM, Song QL, et al
    Influence of menstrual status and pathological type on the apparent diffusion coefficient in cervical cancer: a primary study.
    Acta Radiol. 2020 Jun 14:284185120926897. doi: 10.1177/0284185120926897.
    PubMed         Abstract available

    Arch Med Res

  3. RODRIGUEZ-ESQUIVEL M, Romero-Morelos P, Taniguchi-Ponciano K, Mendoza-Rodriguez M, et al
    Expression of Pregnancy Specific beta-1 Glycoprotein 1 in Cervical Cancer Cells.
    Arch Med Res. 2020 Jun 13. pii: S0188-4409(19)30110.
    PubMed         Abstract available


  4. WOLF B, Espig O, Stolzenburg JU, Horn LC, et al
    Preservation of the mesureter to reduce urinary complications: analysis of data from the observational Leipzig School MMR study.
    BJOG. 2020;127:859-865.
    PubMed         Abstract available

    Cancer Cell Int

  5. LIU Y, Li X, Zhang H, Huang Y, et al
    MIAT inhibits proliferation of cervical cancer cells through regulating miR-150-5p.
    Cancer Cell Int. 2020;20:242.
    PubMed         Abstract available

    Cancer Manag Res

  6. BAI Y, Li X
    hsa_circ_0008285 Facilitates the Progression of Cervical Cancer by Targeting miR-211-5p/SOX4 Axis.
    Cancer Manag Res. 2020;12:3927-3936.
    PubMed         Abstract available

  7. HUANG L, Chen Y, Lai S, Guan H, et al
    CUB Domain-Containing Protein-1 Promotes Proliferation, Migration and Invasion in Cervical Cancer Cells.
    Cancer Manag Res. 2020;12:3759-3769.
    PubMed         Abstract available

  8. CHEN R, Mao L, Shi R, Wang W, et al
    circRNA MYLK Accelerates Cervical Cancer via Up-Regulation of RHEB and Activation of mTOR Signaling.
    Cancer Manag Res. 2020;12:3611-3621.
    PubMed         Abstract available

  9. CHEN X, Zhang Z, Ma Y, Su H, et al
    LINC02381 Promoted Cell Viability and Migration via Targeting miR-133b in Cervical Cancer Cells.
    Cancer Manag Res. 2020;12:3971-3979.
    PubMed         Abstract available

  10. WANG B, Shen Y, Zou Y, Qi Z, et al
    TOP2A Promotes Cell Migration, Invasion and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating the PI3K/AKT Signaling.
    Cancer Manag Res. 2020;12:3807-3814.
    PubMed         Abstract available

    Cancers (Basel)

  11. PEDONE ANCHORA L, Carbone V, Gallotta V, Fanfani F, et al
    Should the Number of Metastatic Pelvic Lymph Nodes be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

  12. NJUGUNA DW, Mahrouseh N, Onisoyonivosekume D, Varga O, et al
    National Policies to Prevent and Manage Cervical Cancer in East African Countries: A Policy Mapping Analysis.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

  13. LOW HY, Lee YC, Lee YJ, Wang HL, et al
    Reciprocal Regulation Between Indoleamine 2,3-Dioxigenase 1 and Notch1 Involved in Radiation Response of Cervical Cancer Stem Cells.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

    Cell Mol Biol (Noisy-le-grand)

  14. GAO Y, Wang H, Zhong A, Yu T, et al
    Expression and prognosis of CyclinA and CDK2 in patients with advanced cervical cancer after chemotherapy.
    Cell Mol Biol (Noisy-le-grand). 2020;66:85-91.
    PubMed         Abstract available

    Clin Lab

  15. QIN S, Chen S, Qin S, Chen H, et al
    Correlation between Pretreatment Hematologic Parameters and Cervical Cancer Patients Undergoing Hysterectomy: a Retrospective Study.
    Clin Lab. 2020;66.
    PubMed         Abstract available

    Enferm Clin

  16. APRILIA R, Arsin AA, Masni
    Determinants of early detection of cervical cancer with visual inspection with acetic acid method among childbearing age women.
    Enferm Clin. 2020;30 Suppl 4:353-356.
    PubMed         Abstract available

  17. NURYANA R, Salmah U, Russeng SS
    Determinant early detection cervical cancer pus with via in the health center of Galesong north Takalar.
    Enferm Clin. 2020;30 Suppl 4:367-370.
    PubMed         Abstract available

    Eur J Cancer

  18. DUGUE PA, Lynge E, Rebolj M
    Comment on 'Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review'.
    Eur J Cancer. 2020 Jun 12. pii: S0959-8049(20)30236.

    Front Immunol

  19. ALSON D, Schuyler SC, Yan BX, Samimuthu K, et al
    Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model.
    Front Immunol. 2020;11:927.
    PubMed         Abstract available

    Gynecol Oncol

  20. SUTARIA T, Sparks AD, Rao YJ, Lopez-Acevedo M, et al
    Trends in guideline-adherent fertility-sparing surgery for early-stage cervical cancer before and after the Affordable Care Act.
    Gynecol Oncol. 2020 Jun 11. pii: S0090-8258(20)31096.
    PubMed         Abstract available

    Int J Gynecol Cancer

  21. KIM YJ, Kim YS, Shin JW, Osong B, et al
    Prediction scoring system based on clinicohematologic parameters for cervical cancer patients undergoing chemoradiation.
    Int J Gynecol Cancer. 2020 Jun 16. pii: ijgc-2019-001050.
    PubMed         Abstract available

    Int J Med Sci

  22. WENG SL, Ng SC, Lee YC, Hsiao YH, et al
    The relationships of genetic polymorphisms of the long noncoding RNA growth arrest-specific transcript 5 with uterine cervical cancer.
    Int J Med Sci. 2020;17:1187-1195.
    PubMed         Abstract available

    J Cancer Educ

  23. LI T, Yoon J, Luck J, Bui LN, et al
    The Impact of Continuity of Care on Cervical Cancer Screening: How Visit Pattern Affects Guideline Concordance.
    J Cancer Educ. 2020 Jun 15. pii: 10.1007/s13187-020-01777.
    PubMed         Abstract available

    J Minim Invasive Gynecol

  24. FERRIER C, Pellevoizin R, Touboul C, Boudy AS, et al
    Back to the future: Schauta-Amreich radical vaginal hysterectomy assisted by laparoscopy with sentinel lymph node biopsy for early-stage cervical cancer.
    J Minim Invasive Gynecol. 2020 Jun 10. pii: S1553-4650(20)30294.
    PubMed         Abstract available

    Lancet Oncol

  25. PETIGNAT P, Kenfack B
    Is thermal ablation a new standard for cervical pre-cancer treatment in low-income and middle-income countries?
    Lancet Oncol. 2020;21:19-20.

  26. BURKI TK
    Therapeutic HPV vaccine for cervical intraepithelial neoplasia.
    Lancet Oncol. 2019 Apr 12. pii: S1470-2045(19)30224.


  27. SHARMA S, Munger K
    Expression of the Long Noncoding RNA DINO in Human Papillomavirus-Positive Cervical Cancer Cells Reactivates the Dormant TP53 Tumor Suppressor through ATM/CHK2 Signaling.
    mBio. 2020;11.
    PubMed         Abstract available

    Medicine (Baltimore)

  28. ZHANG L, Zheng CY, Cao JH, Luo SL, et al
    Efficacy of paclitaxel, carboplatin, and bevacizumab for cervical cancer: A protocol for systematic review and meta-analysis.
    Medicine (Baltimore). 2020;99:e20558.
    PubMed         Abstract available

    Onco Targets Ther

  29. ZHANG B, Lin Y, Bao Q, Zheng Y, et al
    MiR-1193 Inhibits the Malignancy of Cervical Cancer Cells by Targeting Claudin 7 (CLDN7).
    Onco Targets Ther. 2020;13:4349-4358.
    PubMed         Abstract available

  30. LYU M, Shen Y, Beharee N, Lu J, et al
    The Combined Use of Chemotherapy and Radiotherapy with PD-1 Inhibitor, Pembrolizumab, in Advanced Cervical Cancer: A Case Report.
    Onco Targets Ther. 2020;13:4465-4471.
    PubMed         Abstract available

  31. REZAZADEH D, Norooznezhad AH, Mansouri K, Jahani M, et al
    Rapamycin Reduces Cervical Cancer Cells Viability in Hypoxic Condition: Investigation of the Role of Autophagy and Apoptosis.
    Onco Targets Ther. 2020;13:4239-4247.
    PubMed         Abstract available

    Panminerva Med

  32. CHEN F, Yang H, Zhu R
    Analysis of IVIM DWI for the clinical diagnosis of cervical cancer.
    Panminerva Med. 2020 Jun 12. pii: S0031-0808.20.03907.

    Pathol Res Pract

  33. RAHMANI F, Hasanzadeh M, Hassanian SM, Khazaei M, et al
    Association of a genetic variant in the angiopoietin-like protein 4 gene with cervical cancer.
    Pathol Res Pract. 2020;216:153011.
    PubMed         Abstract available


  34. LIU Z, Li Y, She G, Zheng X, et al
    Resveratrol induces cervical cancer HeLa cell apoptosis through the activation and nuclear translocation promotion of FOXO3a.
    Pharmazie. 2020;75:250-254.
    PubMed         Abstract available

    Pharmgenomics Pers Med

  35. WANG B, Wang M, Li X, Yang M, et al
    Variations in the Wnt/beta-Catenin Pathway Key Genes as Predictors of Cervical Cancer Susceptibility.
    Pharmgenomics Pers Med. 2020;13:157-165.
    PubMed         Abstract available

    Sci Rep

  36. TANGO CN, Seo SS, Kwon M, Lee DO, et al
    Taxonomic and Functional Differences in Cervical Microbiome Associated with Cervical Cancer Development.
    Sci Rep. 2020;10:9720.
    PubMed         Abstract available

    Support Care Cancer

  37. SHELAL Z, Cho D, Urbauer DL, Lu Q, et al
    Knowledge matters and empowers: HPV vaccine advocacy among HPV-related cancer survivors.
    Support Care Cancer. 2020;28:2407-2413.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.